Acute venous thromboembolism plasma and red blood cell metabolomic profiling reveals potential new early diagnostic biomarkers: observational clinical study.

"Declarations Ethics approval and consent to participateThe clinical trial part was approved by the Research Committee of the Hospital Beatriz Angelo and the Ethical Commission of INSA. Consent for publicationThis study has not been published before, and this publication has been approved by all authors. Competing interestsThe authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. Competing interests The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper."

"Funding The project was supported by the Instituto Nacional de Saúde de Dr Ricardo Jorge (INSA I.P), ToxOmics-Centre for Toxicogenomics and Human Health (FCT-UID/BIM/00009/2013), RNEM-National Mass Spectrometry Networking-FCT Strategic Infrastructure (LISBOA-01-0145-FEDER-022125 • POCI-01-0145-FEDER-022125) and Fundação para a Ciência e a Tecnologia (FCT)- Fellowship 202214435.BD. This works was also partially financed by Targeted Research Project 2301110175 UOS."